BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 29950204)

  • 1. [Safety and Effectiveness of High Dose Tigecycline for Treating Patients with Acute Leukemia after Ineffctiveness of Carbapenems Chemotherapy Combinating with Febrile Neutropenia: Retrospective study].
    Gao HH; Yao ZL; Li Y; Huang S; Liu J; Jing Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):684-690. PubMed ID: 29950204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical Observation of Neutropenia Patients with Hematonosis Treated with Polymyxin B Sulfate].
    Wu SQ; Zhan R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1596-1600. PubMed ID: 36208272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tigecycline Treatment for Carbapenem-Resistant Enterobacteriaceae Infections: A Systematic Review and Meta-Analysis.
    Ni W; Han Y; Liu J; Wei C; Zhao J; Cui J; Wang R; Liu Y
    Medicine (Baltimore); 2016 Mar; 95(11):e3126. PubMed ID: 26986165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Monte Carlo simulation to evaluate the efficacy of tigecycline and minocycline for the treatment of pneumonia due to carbapenemase-producing Klebsiella pneumoniae.
    Ni W; Li G; Zhao J; Cui J; Wang R; Gao Z; Liu Y
    Infect Dis (Lond); 2018 Jul; 50(7):507-513. PubMed ID: 29316830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tigecycline for treatment of carbapenem-resistant Klebsiella pneumoniae infections after liver transplantation in the intensive care unit: a 3-year study.
    Mouloudi E; Massa E; Piperidou M; Papadopoulos S; Iosifidis E; Roilides I; Theodoridou T; Kydona C; Fouzas I; Imvrios G; Papanikolaou V; Gritsi-Gerogianni N
    Transplant Proc; 2014 Nov; 46(9):3219-21. PubMed ID: 25420864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections.
    Ku K; Pogue JM; Moshos J; Bheemreddy S; Wang Y; Bhargava A; Campbell M; Khandker N; Lephart PR; Chopra T; Hayakawa K; Martin ET; Abreu-Lanfranco O; Dhar S; Kaye KS; Marchaim D
    Am J Infect Control; 2012 Dec; 40(10):983-7. PubMed ID: 22440526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tigecycline: a glycylcycline antimicrobial agent.
    Doan TL; Fung HB; Mehta D; Riska PF
    Clin Ther; 2006 Aug; 28(8):1079-1106. PubMed ID: 16982286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study.
    Wu X; Zhu Y; Chen Q; Gong L; Lin J; Lv D; Feng J
    Biomed Res Int; 2016; 2016():8395268. PubMed ID: 28044137
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of Tigecycline as Salvage Therapy in Multidrug-Resistant Febrile Neutropenia in Patients with Acute Leukemia-A Single Center Analysis.
    Modemann F; Härterich S; Schulze Zur Wiesch J; Rohde H; Lindeman NB; Bokemeyer C; Fiedler W; Ghandili S
    Antibiotics (Basel); 2022 Jan; 11(2):. PubMed ID: 35203731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tigecycline as salvage treatment of febrile neutropenia in patients with haematological malignancies-a retrospective single-centre analysis of 200 cases.
    Geßner D; Berisha M; Esser T; Schalk E
    Ann Hematol; 2023 Sep; 102(9):2607-2616. PubMed ID: 37186157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [[The profile of antibiotic resistantpathogens isolated from ascites fluid patients in intensive care unit during past 12 years].
    Kong Q; Hu L; Zhou Z; Shen J; Xu X; Ye Y; Zhang Z; Li J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Mar; 28(3):211-6. PubMed ID: 29916671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with tigecycline in the treatment of carbapenem-resistant Acinetobacter infections.
    Metan G; Alp E; Yildiz O; Percin D; Aygen B; Sumerkan B
    J Chemother; 2010 Apr; 22(2):110-4. PubMed ID: 20435570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bloodstream infections caused by Acinetobacter species with reduced susceptibility to tigecycline: clinical features and risk factors.
    Park GE; Kang CI; Cha MK; Cho SY; Seok H; Lee JH; Kim JY; Ha YE; Chung DR; Peck KR; Lee NY; Song JH
    Int J Infect Dis; 2017 Sep; 62():26-31. PubMed ID: 28676346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experience with tigecycline compassionate use in pediatric patients infected with carbapenem resistant Klebsiella pneumoniae].
    Hurtado IC; Trujillo M; Restrepo A; Garcés C; Tamayo C; Mesa JG
    Rev Chilena Infectol; 2012 Jun; 29(3):317-21. PubMed ID: 23096472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infections.
    Falagas ME; Vardakas KZ; Tsiveriotis KP; Triarides NA; Tansarli GS
    Int J Antimicrob Agents; 2014 Jul; 44(1):1-7. PubMed ID: 24602499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
    Ye JJ; Lin HS; Yeh CF; Wu YM; Huang PY; Yang CC; Huang CT; Lee MH
    BMC Infect Dis; 2016 Aug; 16():374. PubMed ID: 27496018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minocycline and Tigecycline: What Is Their Role in the Treatment of Carbapenem-Resistant Gram-Negative Organisms?
    Shankar C; Nabarro LEB; Anandan S; Veeraraghavan B
    Microb Drug Resist; 2017 Jun; 23(4):437-446. PubMed ID: 27564414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective survey and evaluation of first-line antibiotics for chemotherapy-induced febrile neutropenia in patients with acute myeloid leukemia.
    Mukoyama N; Nakashima M; Miyamura K; Yoshimi A; Noda Y; Mori K
    Nagoya J Med Sci; 2017 Feb; 79(1):17-26. PubMed ID: 28303057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residence in Skilled Nursing Facilities Is Associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae.
    van Duin D; Cober E; Richter SS; Perez F; Kalayjian RC; Salata RA; Evans S; Fowler VG; Bonomo RA; Kaye KS
    Infect Control Hosp Epidemiol; 2015 Aug; 36(8):942-8. PubMed ID: 25990806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tigecycline in the management of post-neurosurgical spondylodiscitis: a review of eight cases.
    Sipahi OR; Kahraman H; Mermer S; Pullukcu H; Tasbakan M; Arda B; Yamazhan T; Yurtseven T; Aydemir S; Ulusoy S
    Int J Infect Dis; 2014 Jun; 23():16-9. PubMed ID: 24657273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.